Yahoo
Capricor Therapeutics (CAPR) announced the completion of the Food and Drug Administration’s pre-license inspection of its San Diego manufacturing facility for Deramiocel, the company’s lead cell therapy candidate with a biologics license application under FDA review for potential approval in the treatment of Duchenne muscular dystrophy. The inspection concluded with a Form 483 containing several observations. Capricor said it has submitted its responses to the FDA, none of which required materia
Finnhub
NEW YORK, June 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. . Such investors are advised to contact Danielle Peyton at...
SeekingAlpha
Capricor Therapeutics' rating was downgraded amid FDA inspection risks, regulatory uncertainty, and potential delays in approval for deramiocel. Read more on CAPR stock here.
Yahoo
U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to support licensureAdvisory Committee meeting scheduled for July 30, 2025Mid-cycle meeting recently completed with no significant issues or major deficiencies; late-cycle meeting planned for mid-JulyBiologics License Application remains under priority review with PDUFA target action date of August 31, 2025 SAN DIEGO, June 11, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR),
SeekingAlpha
Capricor Therapeutics leads with Deramiocel for DMD and StealthX tech, backed by trials, NS Pharma deal, and cash. See why CAPR stock is a buy.
Yahoo
The United States market is experiencing a slight rebound, with major indices like the Dow Jones and S&P 500 inching upwards after recent sell-offs, while bond yields retreat from their highs. In this environment of fluctuating market sentiment and economic uncertainty, identifying high growth tech stocks requires careful consideration of their potential to innovate and adapt within the dynamic landscape.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -17.33% | $153.01M | 0.85% |
TAIL | -16.98% | $107.77M | 0.59% |
IVOL | -16.92% | $358.39M | 1.02% |
IBTG | -15.65% | $1.94B | 0.07% |
FXY | -15.61% | $857.17M | 0.4% |
UTWO | -15.48% | $374.41M | 0.15% |
SCHO | -14.18% | $10.93B | 0.03% |
SPTS | -14.17% | $5.78B | 0.03% |
XONE | -13.88% | $634.70M | 0.03% |
BTAL | -12.78% | $298.87M | 1.43% |
GBIL | -12.67% | $6.05B | 0.12% |
VGSH | -11.58% | $22.40B | 0.03% |
IBTH | -11.16% | $1.57B | 0.07% |
IBTI | -10.94% | $1.02B | 0.07% |
XHLF | -10.83% | $1.64B | 0.03% |
TDTT | -10.73% | $2.58B | 0.18% |
SHY | -10.32% | $23.88B | 0.15% |
STPZ | -10.11% | $451.45M | 0.2% |
UDN | -9.68% | $145.23M | 0.78% |
VNLA | -9.59% | $2.57B | 0.23% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 28.40% | $44.34M | 0.5% |
XBI | 27.67% | $4.89B | 0.35% |
IBB | 24.38% | $5.23B | 0.45% |
IWC | 24.10% | $813.58M | 0.6% |
WOOD | 23.16% | $207.05M | 0.41% |
ESPO | 23.12% | $365.36M | 0.56% |
HERO | 23.03% | $151.90M | 0.5% |
ARKG | 22.92% | $980.60M | 0.75% |
PTH | 22.80% | $104.10M | 0.6% |
PJUL | 22.01% | $885.32M | 0.79% |
PSFF | 22.00% | $466.96M | 0.75% |
BLCN | 21.84% | $47.48M | 0.68% |
XRT | 21.72% | $228.43M | 0.35% |
XPH | 21.60% | $153.36M | 0.35% |
PSTP | 21.57% | $108.96M | 0.89% |
EFIV | 21.44% | $1.10B | 0.1% |
QDF | 21.37% | $1.82B | 0.37% |
SNPE | 21.35% | $1.82B | 0.1% |
BJUL | 21.33% | $237.12M | 0.79% |
USMC | 21.29% | $2.92B | 0.12% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
KRBN | -0.03% | $161.71M | 0.85% |
ENZL | -0.04% | $72.84M | 0.5% |
HYD | 0.05% | $3.28B | 0.32% |
SHV | 0.06% | $20.36B | 0.15% |
RING | 0.06% | $1.53B | 0.39% |
IAGG | -0.07% | $10.25B | 0.07% |
TBIL | 0.07% | $5.91B | 0.15% |
BNO | -0.19% | $87.69M | 1% |
JSI | -0.19% | $824.42M | 0.49% |
AVIG | -0.22% | $1.09B | 0.15% |
DFCF | -0.26% | $6.92B | 0.17% |
GCOR | -0.29% | $564.34M | 0.08% |
USL | 0.29% | $40.41M | 0.85% |
ZROZ | -0.31% | $1.49B | 0.15% |
FMB | -0.37% | $1.89B | 0.65% |
BLV | 0.39% | $5.61B | 0.03% |
IBDQ | 0.46% | $3.04B | 0.1% |
GTO | -0.48% | $1.92B | 0.35% |
BSCU | 0.49% | $1.59B | 0.1% |
JBND | -0.52% | $2.13B | 0.25% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SNDX | 29.49% | $937.92M | -46.23% | 0.00% |
ABEO | 28.81% | $318.19M | +38.22% | 0.00% |
NGNE | 28.65% | $298.36M | -43.73% | 0.00% |
RNA | 28.33% | $3.86B | -16.55% | 0.00% |
ARCT | 27.90% | $337.38M | -59.95% | 0.00% |
ZCMD | 27.72% | $26.26M | -13.33% | 0.00% |
YMAB | 27.02% | $223.31M | -58.98% | 0.00% |
AMLX | 26.95% | $483.14M | +216.96% | 0.00% |
CRSP | 26.93% | $3.59B | -35.96% | 0.00% |
MFA | 26.90% | $989.57M | -9.91% | 14.51% |
VSTM | 26.83% | $328.05M | +67.70% | 0.00% |
XNCR | 26.46% | $677.55M | -56.77% | 0.00% |
IMNM | 26.36% | $825.75M | -40.69% | 0.00% |
SRPT | 26.35% | $3.72B | -68.49% | 0.00% |
ACLX | 26.06% | $3.65B | +20.18% | 0.00% |
ENR | 25.87% | $1.57B | -23.46% | 5.55% |
KRYS | 25.68% | $4.03B | -23.27% | 0.00% |
THO | 25.45% | $4.67B | -9.79% | 2.27% |
VYGR | 25.32% | $187.04M | -61.01% | 0.00% |
CATX | 25.26% | $243.47M | -75.34% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TTE | -0.02% | $137.92B | -10.00% | 5.35% |
DFDV | 0.03% | $380.05M | +2,345.35% | 0.00% |
EVH | -0.03% | $1.01B | -62.74% | 0.00% |
DLTR | -0.04% | $19.66B | -13.47% | 0.00% |
VZ | 0.08% | $184.42B | +9.98% | 6.26% |
QNRX | 0.09% | $4.99M | -65.84% | 0.00% |
MMC | 0.10% | $107.06B | +3.24% | 1.49% |
CASI | 0.10% | $28.29M | -43.29% | 0.00% |
EVRI | 0.11% | $1.23B | +68.81% | 0.00% |
HCA | -0.13% | $88.43B | +7.86% | 0.73% |
V | -0.14% | $723.91B | +38.10% | 0.61% |
MNR | 0.14% | $1.67B | -26.73% | 19.54% |
ACEL | -0.15% | $983.53M | +11.84% | 0.00% |
MUSA | 0.16% | $8.20B | -12.51% | 0.46% |
HRB | -0.16% | $7.36B | +7.75% | 2.71% |
KGC | -0.18% | $18.72B | +104.01% | 0.77% |
HUM | 0.19% | $27.97B | -34.24% | 1.52% |
NSP | -0.20% | $2.31B | -35.32% | 3.95% |
WBA | -0.20% | $9.81B | -27.03% | 4.41% |
WBX | 0.22% | $103.94M | -74.65% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CCRN | -19.49% | $431.43M | -9.12% | 0.00% |
CYCN | -13.18% | $9.66M | +32.60% | 0.00% |
GFI | -12.00% | $21.79B | +53.72% | 2.21% |
PINC | -11.93% | $1.85B | +20.84% | 3.74% |
SHLS | -11.36% | $850.92M | -28.01% | 0.00% |
LITB | -10.85% | $21.77M | -74.81% | 0.00% |
SRRK | -10.37% | $3.13B | +251.54% | 0.00% |
DRD | -10.36% | $1.21B | +68.55% | 1.94% |
UNH | -9.94% | $281.72B | -37.01% | 2.65% |
NOC | -9.35% | $70.30B | +14.35% | 1.72% |
LNW | -9.26% | $7.35B | -7.14% | 0.00% |
CBOE | -8.80% | $23.34B | +31.58% | 1.12% |
HSY | -8.31% | $34.05B | -10.24% | 3.23% |
PSQH | -8.11% | $107.02M | -32.86% | 0.00% |
AVNW | -7.84% | $289.26M | -24.69% | 0.00% |
AU | -7.71% | $23.10B | +96.87% | 2.13% |
MCK | -7.51% | $89.80B | +22.74% | 0.39% |
APT | -7.27% | $51.06M | -8.02% | 0.00% |
AORT | -7.14% | $1.24B | +23.20% | 0.00% |
OCX | -6.28% | $75.50M | -4.00% | 0.00% |
Current Value
$12.981 Year Return
Current Value
$12.981 Year Return